CAMLIN FINE SCIENCES LTD. Q4 FY26 Results

Summary

Camlin Fine Sciences Limited announced its financial results for the quarter and year ended March 31, 2026, alongside several key corporate governance changes. The company reported robust consolidated revenue from operations for the full year FY26, growing approximately 79.5% to ₹162,868.75 Lakh. Consolidated Q4 FY26 revenue showed a slight year-on-year increase of about 1.6% to ₹43,158.42 Lakh. In significant corporate actions, Mr. Pankaj Pandey was appointed as the new Chief Financial Officer, while Mr. Santosh Parab was re-designated as President – Strategy and Global CFO. The Board also approved the appointment of new Cost and Internal Auditors for the upcoming financial year.

Key Highlights

1. 1

   Consolidated revenue from operations for the full year ended March 31, 2026, was ₹162,868.75 Lakh, marking a substantial increase of approximately 79.5% compared to ₹90,710.66 Lakh in the previous fiscal year.

2. 2

   For the fourth quarter of FY26, consolidated revenue from operations reached ₹43,158.42 Lakh, showing a modest year-on-year growth of about 1.6% from ₹42,481.12 Lakh in Q4 FY25.

3. 3

   Standalone revenue from operations for the financial year FY26 increased by approximately 64.4% to ₹88,649.13 Lakh, up from ₹53,922.47 Lakh in FY25.

4. 4

   The Board approved the appointment of Mr. Pankaj Pandey as the new Chief Financial Officer (CFO) and Key Managerial Personnel of the Company, effective August 18, 2026.

5. 5

   Mr. Santosh Parab, currently the Chief Financial Officer, will be re-designated as President – Strategy and Global CFO, effective upon Mr. Pandey's joining.

6. 6

   M/s. ABK & Associates and M/s. Mahajan & Aibara were appointed as the Cost Auditors and Internal Auditors, respectively, for the financial year ending March 31, 2027.

7. 7

   The 33rd Annual General Meeting of the Company is scheduled to be held on Tuesday, August 11, 2026.